Global Pertussis Vaccine Market Data Survey Report 2025
- HEY1469574
- 80 Pages
- August 2017
- Pharmaceuticals
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
The global Pertussis Vaccine market will reach xxx Million USD in 2017 with CAGR xx% from 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Average market price by SUK
Major applications
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Astellas Pharma
Minhai Biotechnology
Wuhan Institute of
Biological Products
Changchun Changsheng
Life Sciences
Beijing Tiantan
Biological Products
Chengdu Institute of
Biological Products
Major applications as follows:
Children
Adults
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 Sanofi Pasteur
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 GSK
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Mitsubishi Tanabe Pharma
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Astellas Pharma
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Minhai Biotechnology
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Wuhan Institute of
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Biological Products
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Changchun Changsheng
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Life Sciences
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Beijing Tiantan
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Biological Products
3.12 Chengdu Institute of
3.13 Biological Products
4 Major Application
4.1 Children
4.1.1 Overview
4.1.2 Children Market Size and Forecast
4.2 Adults
4.2.1 Overview
4.2.2 Adults Market Size and Forecast
5 Market Price
5.1 Overview
5.2 Price by SUK
6 Conclusion
List Of Tables
Tab Regional Production 2011-2017 (Value)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Value)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Value)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Value)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Value)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Sanofi Pasteur
Tab Sales Revenue, Volume, Price, Cost and Margin of GSK
Tab Sales Revenue, Volume, Price, Cost and Margin of Mitsubishi Tanabe Pharma
Tab Sales Revenue, Volume, Price, Cost and Margin of Astellas Pharma
Tab Sales Revenue, Volume, Price, Cost and Margin of Minhai Biotechnology
Tab Sales Revenue, Volume, Price, Cost and Margin of Wuhan Institute of
Tab Sales Revenue, Volume, Price, Cost and Margin of Biological Products
Tab Sales Revenue, Volume, Price, Cost and Margin of Changchun Changsheng
Tab Sales Revenue, Volume, Price, Cost and Margin of Life Sciences
Tab Sales Revenue, Volume, Price, Cost and Margin of Beijing Tiantan
Tab Sales Revenue, Volume, Price, Cost and Margin of Biological Products
Tab Sales Revenue, Volume, Price, Cost and Margin of Chengdu Institute of
Tab Sales Revenue, Volume, Price, Cost and Margin of Biological Products
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)
List Of Figures
Fig Global Pertussis Vaccine Market Size and CAGR 2011-2017 (Value)
Fig Global Pertussis Vaccine Market Size and CAGR 2011-2017 (Volume)
Fig Global Pertussis Vaccine Market Forecast and CAGR 2018-2025 (Value)
Fig Global Pertussis Vaccine Market Forecast and CAGR 2018-2025 (Volume)
Fig Children Market Size and CAGR 2011-2017 (Value)
Fig Children Market Size and CAGR 2011-2017 (Volume)
Fig Children Market Forecast and CAGR 2018-2025 (Value)
Fig Children Market Forecast and CAGR 2018-2025 (Volume)
Fig Adults Market Size and CAGR 2011-2017 (Value)
Fig Adults Market Size and CAGR 2011-2017 (Volume)
Fig Adults Market Forecast and CAGR 2018-2025 (Value)
Fig Adults Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
